|
⚲
|
| Keyboard |
| Arthur Pappas | |
|---|---|
| Firm | Pappas Capital LLC |
| Address | 2520 Meridian Pkwy, Suite 400 Durham, NC 27713 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Pappas Capital LLC | |||||
| PV VI CEO Fund LP | 021-437189 | Director | of 25.0 M |
5.9 M | |
| Asia Innovation Ventures LP | 021-413785 | Director | 200.0 M of 200.0 M |
84.0 M | |
| AM Pappas Life Science Ventures V LP | 021-281210 | Director | 85.8 M of 85.8 M |
9.6 M | |
| PV V CEO Fund LP | 021-281212 | Director | 7.0 M of 7.0 M |
0.9 M | |
| PV IV CEO Fund LP | 021-130778 | Promoter | 3.9 M of 3.9 M |
0.1 M | |
| Afferent Pharmaceuticals Inc | 021-243651 | Director | 55.0 M of 55.0 M |
||
| Colucid Pharmaceuticals Inc | 021-232838 | Executive Officer | 37.1 M of 37.1 M |
||
| TYRX Inc | 021-196569 | Director | 2.0 M of 2.0 M |
||
| TYRX Inc | 021-189287 | Director | 2.0 M of 2.1 M |
||
| Cardiodx Inc | 021-183494 | Director | 30.5 M of 58.0 M |
||
| TYRX Inc | 021-173235 | Director | 2.5 M of 5.2 M |
||
| Braincells Inc | 021-171611 | Director | 4.1 M of 9.0 M |
||
| Cenerx Biopharma Inc | 021-169397 | Director | 5.2 M of 5.2 M |
||
| Colucid Pharmaceuticals Inc | 021-156147 | Executive Officer | 8.2 M of 9.5 M |
||
| Cardiodx Inc | 021-156088 | Director | 57.5 M of 78.3 M |
||
| Chimerix Inc | 021-155415 | Director | 45.0 M of 68.7 M |
||
| TYRX Pharma Inc | 021-151474 | Director | 23.1 M of 25.2 M |
||
| Cenerx Biopharma Inc | 021-146225 | Director | 7.0 M of 7.0 M |
||
| Cardiodx Inc | 021-142039 | Director | 34.6 M of 44.5 M |
||
| Colucid Pharmaceuticals Inc | 021-84673 | Executive Officer | 9.2 M of 13.8 M |
||
| Afferent Pharmaceuticals Inc | 021-135875 | Director | 3.0 M of 23.0 M |
||
| TYRX Pharma Inc | 021-68851 | Director | 11.0 M of 11.0 M |
||
| Cenerx Biopharma Inc | 021-83235 | Director | 3.5 M of 3.5 M |
||
| Lead Therapeutics Inc | 021-103170 | Director | 3.0 M of 7.0 M |
||